Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Harvard Business School
McKinsey
AstraZeneca
Boehringer Ingelheim

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Torrent Pharmaceuticals Limited v. Daiichi Sankyo, Inc. (N.D. Ill. 2016)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Torrent Pharmaceuticals Limited v. Daiichi Sankyo, Inc. (N.D. Ill. 2016)

Docket   Start Trial Date Filed 2016-03-09
Court District Court, N.D. Illinois Date Terminated 2016-10-03
Cause 28:2201 Declaratory Judgement Assigned To Rebecca R. Pallmeyer
Jury Demand None Referred To
Parties ALEMBIC PHARMACEUTICALS LIMITED; AUROBINDO PHARMA, INC.; AUROBINDO PHARMACEUTICALS LIMITED; DAIICHI SANKYO CO., LTD.; DAIICHI SANKYO, INC.; MYLAN PHARMACEUTICALS INC.; TORRENT PHARMA INC.; TORRENT PHARMACEUTICALS LIMITED
Patents 5,616,599; 6,878,703
Attorneys Autumn N. Nero; C. Austin Ginnings; Christopher Paul Borello; David C. Van Dyke; David R. Pekarek Krohn; Dominick A Conde; Emily Elizabeth Bennett; James B Coughlan; Joseph E. Cwik; Kristen Elizabeth Hudson; Maria Alice Stubbings; Nina Shreve; Paul F. Stack; Shannon M. Bloodworth; Shashank S. Upadhye; Stephen Arthur Wood
Firms BR>Trial Bar Status: Active; BR>Trial Bar Status: Not a Member; BR>Trial Bar Status: Pro Hac Vice
Link to Docket External link to docket
Small Molecule Drugs cited in Torrent Pharmaceuticals Limited v. Daiichi Sankyo, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Torrent Pharmaceuticals Limited v. Daiichi Sankyo, Inc. (N.D. Ill. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-07-25 106 drug"). United States Patent No. 5,616,599 ("the '599 patent) covers the drug's active…owns certain patents, including United States Patent No. 6,878,703 ("the '703 patent"), concerning…infringe the '703 patent because Defendants have already disclaimed the patent. Mylan has filed a motion…requiring applicants to list patents "with respect to which a claim of patent infringement could reasonably… 3 of the patent on July 11, 2006. (Id. ΒΆΒΆ 24, 29.) 3 With the '703 patent disclaimed, approved External link to document
2016-06-08 92 Summary Judgment of Non-Infringement of U.S. Patent 6,878,703 (Wood, Stephen) (Entered: 06/08/2016) …2016 3 October 2016 1:16-cv-02988 830 Patent None District Court, N.D. Illinois External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Express Scripts
Baxter
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.